Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Drug delivery
Reexamination Certificate
2006-11-01
2010-02-23
Gherbi, Suzette J (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Drug delivery
Reexamination Certificate
active
07666222
ABSTRACT:
Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
REFERENCES:
patent: 3797485 (1974-03-01), Urquhart
patent: 5100422 (1992-03-01), Berguer et al.
patent: 5234456 (1993-08-01), Silvestrini
patent: 5282823 (1994-02-01), Schwartz et al.
patent: 5283257 (1994-02-01), Gregory et al.
patent: 5288711 (1994-02-01), Mitchell et al.
patent: 5342348 (1994-08-01), Kaplan
patent: 5383928 (1995-01-01), Scott et al.
patent: 5443496 (1995-08-01), Schwartz et al.
patent: 5449382 (1995-09-01), Dayton
patent: 5464450 (1995-11-01), Buscemi et al.
patent: 5464650 (1995-11-01), Berg et al.
patent: 5500013 (1996-03-01), Buscemi et al.
patent: 5510077 (1996-04-01), Dinh et al.
patent: 5516781 (1996-05-01), Morris et al.
patent: 5519042 (1996-05-01), Morris et al.
patent: 5545208 (1996-08-01), Wolff et al.
patent: 5551954 (1996-09-01), Buscemi et al.
patent: 5554182 (1996-09-01), Dinh et al.
patent: 5562922 (1996-10-01), Lambert
patent: 5563146 (1996-10-01), Morris et al.
patent: 5571166 (1996-11-01), Dinh et al.
patent: 5578075 (1996-11-01), Dayton
patent: 5591224 (1997-01-01), Schwartz et al.
patent: 5591227 (1997-01-01), Dinh et al.
patent: 5599352 (1997-02-01), Dinh et al.
patent: 5603722 (1997-02-01), Phan et al.
patent: 5605696 (1997-02-01), Eury et al.
patent: 5607463 (1997-03-01), Schwartz et al.
patent: 5607475 (1997-03-01), Cahalan et al.
patent: 5609629 (1997-03-01), Fearnot et al.
patent: 5624411 (1997-04-01), Tuch
patent: 5628785 (1997-05-01), Schwartz et al.
patent: 5629077 (1997-05-01), Turnlund et al.
patent: 5632840 (1997-05-01), Campbell
patent: 5637113 (1997-06-01), Tartaglia et al.
patent: 5646160 (1997-07-01), Morris et al.
patent: 5649977 (1997-07-01), Campbell
patent: 5651174 (1997-07-01), Schwartz et al.
patent: 5665728 (1997-09-01), Morris et al.
patent: 5672638 (1997-09-01), Verhoeven et al.
patent: 5674242 (1997-10-01), Phan et al.
patent: 5679400 (1997-10-01), Tuch
patent: 5679659 (1997-10-01), Verhoeven et al.
patent: 5693085 (1997-12-01), Buirge et al.
patent: 5697967 (1997-12-01), Dinh et al.
patent: 5700286 (1997-12-01), Tartaglia et al.
patent: 5707385 (1998-01-01), Williams
patent: 5725567 (1998-03-01), Wolff et al.
patent: 5728150 (1998-03-01), McDonald et al.
patent: 5728420 (1998-03-01), Keogh
patent: 5733327 (1998-03-01), Igaki et al.
patent: 5735897 (1998-04-01), Buirge
patent: 5755772 (1998-05-01), Evans et al.
patent: 5769883 (1998-06-01), Buscemi et al.
patent: 5776184 (1998-07-01), Tuch
patent: 5782908 (1998-07-01), Cahalan et al.
patent: 5788979 (1998-08-01), Alt et al.
patent: 5799384 (1998-09-01), Schwartz et al.
patent: 5800507 (1998-09-01), Schwartz
patent: 5820917 (1998-10-01), Tuch
patent: 5820918 (1998-10-01), Ronan et al.
patent: 5824048 (1998-10-01), Tuch
patent: 5824049 (1998-10-01), Ragheb et al.
patent: 5833651 (1998-11-01), Donovan et al.
patent: 5837008 (1998-11-01), Berg et al.
patent: 5837313 (1998-11-01), Ding et al.
patent: 5843172 (1998-12-01), Yan
patent: 5849034 (1998-12-01), Schwartz
patent: 5851217 (1998-12-01), Wolff et al.
patent: 5851231 (1998-12-01), Wolff et al.
patent: 5865814 (1999-02-01), Tuch
patent: 5871535 (1999-02-01), Wolff et al.
patent: 5879697 (1999-03-01), Ding et al.
patent: 5882335 (1999-03-01), Leone et al.
patent: 5900433 (1999-05-01), Igo et al.
patent: 5981568 (1999-11-01), Kunz et al.
patent: 6273913 (2001-08-01), Wright et al.
patent: 6306421 (2001-10-01), Kunz et al.
patent: 6335029 (2002-01-01), Kamath et al.
patent: 6517889 (2003-02-01), Jayaraman
patent: 6575887 (2003-06-01), Schrayer
patent: 6585764 (2003-07-01), Wright et al.
patent: 6808536 (2004-10-01), Wright et al.
patent: 6921414 (2005-07-01), Klumb et al.
patent: 7217286 (2007-05-01), Falotico et al.
patent: 7223286 (2007-05-01), Wright et al.
patent: 7229473 (2007-06-01), Falotico et al.
patent: 7387604 (2008-06-01), Case et al.
patent: 2002/0068969 (2002-06-01), Shanley et al.
patent: 2002/0099438 (2002-07-01), Furst
patent: 2002/0123505 (2002-09-01), Mollison et al.
patent: 2003/0065377 (2003-04-01), Davila et al.
patent: 2008/0317827 (2008-12-01), Wright et al.
patent: 0 568 310 (1993-11-01), None
patent: 0 712 615 (1996-05-01), None
patent: 0 716 836 (1996-06-01), None
patent: 0 761 251 (1997-03-01), None
patent: 0 850 651 (1998-07-01), None
patent: 0 938 878 (1999-09-01), None
patent: 0 950 386 (1999-10-01), None
patent: WO 96/32907 (1996-10-01), None
patent: WO 97/33534 (1997-09-01), None
patent: WO 97/40755 (1997-11-01), None
patent: WO 98/23228 (1998-06-01), None
patent: WO 98/34669 (1998-08-01), None
patent: WO 98/36784 (1998-08-01), None
patent: WO 98/43618 (1998-10-01), None
patent: WO 98/47447 (1998-10-01), None
patent: WO 98/56312 (1998-12-01), None
patent: WO 00/21584 (2000-04-01), None
patent: WO 00/27445 (2000-05-01), None
patent: WO 00/32255 (2000-06-01), None
patent: WO 01/87342 (2001-11-01), None
patent: WO 03/015664 (2003-02-01), None
patent: WO 03/057218 (2003-07-01), None
patent: WO 02/26281 (2009-04-01), None
Marx, S.O. et al., Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells, Circulation Research, 1995;76(3):412-417.
Serruys, P.W. et al., Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries, Circulation. 1996;93:412-422.
Lundergan, C.F., MD et al., Peptide Inhibition of Myointimal Proliferation by Angiopeptin, a Somatostatin Analogue, Jacc vol. 17, No. 6, May 1991:132B-6B.
Liu, M.W. et al., Restenosis After Coronary Angioplasty Potential Biologic Determinants and Role of Intimal Hyperplasia, Circulation 1989, 79:1374-1387.
Serruys, P. W. et al., Evaulation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty--A Multicenter Randomized Double-Blind Placbo-Controlled Trial, Circulartion vol. 88, No. 4, Part 1, Oct. 1993, 1588-1601.
Berk, B.C. et al., Pharmacologic Roles of Heparin and Glucocorticoids to Prevent Restenosis After Coronary Angioplasty, Jacc vol. 17, No. 6, May 1991:111B-7B.
Serruys, P.W. et al. A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease, The New England Journal of Medicine, vol. 331, No. 8, Aug. 25, 1994, 489-495.
Fischman, D.L. et al., A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease, The New England Journal of Medicine, vol. 331, No. 8, Aug. 25, 1994, 496-501.
Colburn, M.D. et al., Dose Responsive suppression of myointimal hyperlasia by dexamethasone, Journal of Vascular Surgery, vol. 15, No. 3, Mar. 1992, 510-518.
Liu, M.W., Trapidil in Preventing Restenosis After Balloon Angioplasty in the Atherosclerotic Rabbit, Circulation, vol. 81, No. 3, Mar. 1990, 1089-1093.
Hansson, G.K. et al., Interferon—Inhibits Arterial Stenosis After Injury, Circulation, vol. 84, No. 3, Sept. 1991, 1266-1272.
Snow, A.D. et al., Heparin Modulates the Composition of th Extracellular Matrix Domain Surrounding Arterial Smooth Muscle Cells, American Journal of Pathology, vol. 137, No. 2, Aug. 1990, 313-330.
Popma, J.J. et al., Clinical Trials of Restenosis After Coronary Angioplasty, Circulation vol. 84, No. 3, Sep. 1991, 1426-1436.
Campbell, G.R. et al., Phenotypic Modulation of Smooth Muscle Cells in Primary Culture, Vascular Smooth Muscle Cells in Culture, Crc Press 1987, pp. 39-55.
Clowes, A.W. et al., Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery, Cir Res 56: 139-145, 1985.
Lange, R.A. et al., Restenosis After Coronary Balloon Angioplasty, Annu. Rev. Med. 1991, 42:127-32.
Franklin, S.M. et al., Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials, Coronary Artery Disease, Mar. 1993, vol. 4, No. 3, 232-242.
Clowes, a.W. et al., Suppression by heparin of smooth muscle cell proliferation in
King Kristen
Llanos Gerard H.
Rakos Ronald
Wright Carol
Cordis Corporation
Gherbi Suzette J
Woodcock & Washburn LLP
LandOfFree
Methods and devices for delivering therapeutic agents to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and devices for delivering therapeutic agents to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and devices for delivering therapeutic agents to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4203252